Rob brings over 25 years of experience in the pharmaceutical industry. He is recognized for his forward-thinking and strategic leadership, leveraging deep industry expertise to drive innovation, elevate operational excellence, and advance patient-centric solutions that improve patient access and ongoing support.
Prior to joining Valeris, Rob held multiple US Commercial Leadership roles including business unit leadership as well as leading GSK’s U.S. Market Access team, with strategic and operational responsibility across all market access functions, including payer marketing, account management, trade strategies, revenue management, government price reporting, and patient services. He was also a core member of the U.S. commercial leadership team, playing a key role in shaping commercial strategies and driving the growth and transformation of GSK’s U.S. pharmaceutical business.
Before his tenure at GSK, he spent over 20 years in the biopharmaceutical industry, holding leadership roles in sales, marketing, and market access at leading companies including EMD Serono, UCB Inc., and Johnson & Johnson. At EMD Serono, he served as Senior Vice President of Oncology Business unit as well as Market Access & Customer Solutions team, where he led U.S. market access strategies, launch preparations and payer contracting to improve patient access to medicines.
Rob holds a Bachelor of Science degree in Marketing and an MBA in Finance and Financial Management from the University of Central Florida. He is also a veteran of the U.S. Coast Guard. He has been with his wife Kim for almost 30 years, and they have two daughter, Aly & Kaitlyn who both currently attend the University of Central Florida in Orlando, FL.